2.92
前日終値:
$2.95
開ける:
$2.97
24時間の取引高:
3.12M
Relative Volume:
0.90
時価総額:
$774.22M
収益:
$194.75M
当期純損益:
$-51.26M
株価収益率:
-10.43
EPS:
-0.28
ネットキャッシュフロー:
$-23.38M
1週間 パフォーマンス:
+1.04%
1か月 パフォーマンス:
+3.18%
6か月 パフォーマンス:
+53.68%
1年 パフォーマンス:
+119.55%
Akebia Therapeutics Inc Stock (AKBA) Company Profile
名前
Akebia Therapeutics Inc
セクター
電話
617-871-2098
住所
245 FIRST STREET, CAMBRIDGE, MA
AKBA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
AKBA
Akebia Therapeutics Inc
|
2.92 | 739.75M | 194.75M | -51.26M | -23.38M | -0.28 |
![]()
ZTS
Zoetis Inc
|
143.26 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.88 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
![]()
HLN
Haleon Plc Adr
|
9.20 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.63 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
![]()
UTHR
United Therapeutics Corp
|
432.69 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Akebia Therapeutics Inc Stock (AKBA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-04 | 再開されました | H.C. Wainwright | Buy |
2025-04-28 | 開始されました | Leerink Partners | Outperform |
2025-04-01 | 開始されました | Jefferies | Buy |
2023-11-29 | 再開されました | BTIG Research | Buy |
2023-08-28 | アップグレード | H.C. Wainwright | Neutral → Buy |
2023-05-31 | アップグレード | Piper Sandler | Neutral → Overweight |
2022-03-31 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2022-03-31 | ダウングレード | Mizuho | Buy → Neutral |
2022-03-31 | ダウングレード | Needham | Buy → Hold |
2022-03-31 | ダウングレード | Piper Sandler | Overweight → Neutral |
2021-03-08 | 開始されました | Cantor Fitzgerald | Overweight |
2021-01-29 | ダウングレード | JP Morgan | Neutral → Underweight |
2019-11-14 | 繰り返されました | Needham | Buy |
2019-08-06 | 繰り返されました | H.C. Wainwright | Buy |
2019-07-11 | 繰り返されました | H.C. Wainwright | Buy |
2019-05-02 | 開始されました | JP Morgan | Overweight |
2019-03-20 | 開始されました | Citigroup | Neutral |
2018-09-07 | 再開されました | Morgan Stanley | Equal-Weight |
2018-08-10 | 繰り返されました | Needham | Buy |
2018-06-06 | 繰り返されました | H.C. Wainwright | Buy |
2017-12-19 | 開始されました | Piper Jaffray | Overweight |
2017-12-07 | 開始されました | BTIG Research | Buy |
2017-09-15 | 開始されました | RBC Capital Mkts | Sector Perform |
2017-07-10 | 繰り返されました | H.C. Wainwright | Buy |
2017-04-27 | 繰り返されました | H.C. Wainwright | Buy |
2017-04-27 | 繰り返されました | Needham | Buy |
2016-12-27 | 繰り返されました | H.C. Wainwright | Buy |
2016-12-20 | 繰り返されました | JMP Securities | Mkt Outperform |
2016-11-15 | 開始されました | Aegis Capital | Buy |
2016-09-29 | 開始されました | Brean Capital | Buy |
2016-03-16 | 繰り返されました | Needham | Buy |
2016-01-21 | 開始されました | Credit Suisse | Neutral |
すべてを表示
Akebia Therapeutics Inc (AKBA) 最新ニュース
Real time breakdown of Akebia Therapeutics Inc. stock performanceWeekly Trade Summary & AI Enhanced Trading Signals - newser.com
How rising interest rates impact Akebia Therapeutics Inc. stockJuly 2025 Drop Watch & Daily Profit Focused Stock Screening - newser.com
Will Akebia Therapeutics Inc. (AX9) stock profit from AI boomJuly 2025 Fed Impact & High Conviction Investment Ideas - newser.com
Akebia slumps after Q4 earnings miss - MSN
Is this a good reentry point in Akebia Therapeutics Inc.July 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
Applying Elliott Wave Theory to Akebia Therapeutics Inc.2025 EndofYear Setup & Step-by-Step Swing Trade Plans - newser.com
Should I hold or sell Akebia Therapeutics Inc. stock in 2025Earnings Overview Summary & Consistent Return Strategy Ideas - newser.com
Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics - Yahoo Finance
Order flow analysis tools used on Akebia Therapeutics Inc.Market Weekly Review & Daily Volume Surge Signals - newser.com
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Zacks Investment Research
What makes Akebia Therapeutics Inc. stock attractive to growth fundsJuly 2025 Action & Community Consensus Picks - newser.com
Applying chart zones and confluence areas to Akebia Therapeutics Inc.Quarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com
What to expect from Akebia Therapeutics Inc. in the next 30 daysCPI Data & Fast Gaining Stock Strategy Reports - newser.com
Akebia Therapeutics Achieves Multibagger Status with 123.31% Stock Increase Over Past Year - Markets Mojo
Can technical indicators confirm Akebia Therapeutics Inc.’s reversalJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Potential 156% Upside Sparks Interest - DirectorsTalk Interviews
What machine learning models say about Akebia Therapeutics Inc.Quarterly Trade Summary & High Win Rate Trade Tips - newser.com
How Akebia Therapeutics Inc. stock performs in interest rate cycles2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Why Akebia Therapeutics Inc. (AX9) stock is a strong buy callQuarterly Portfolio Summary & Smart Allocation Stock Tips - newser.com
How Akebia Therapeutics Inc. stock reacts to inflationary pressuresTrade Ideas & Fast Exit and Entry Strategy Plans - newser.com
Published on: 2025-10-09 05:00:40 - newser.com
Can Akebia Therapeutics Inc. (AX9) stock resist broad market declinesQuarterly Trade Summary & AI Powered Market Entry Ideas - newser.com
How Akebia Therapeutics Inc. (AX9) stock moves in volatile trading sessions2025 Institutional Moves & Daily Chart Pattern Signals - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Akebia Therapeutics (NASDAQ:AKBA) - MarketBeat
Is Intellia Therapeutics (NTLA) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Profit Outlook - simplywall.st
What drives Akebia Therapeutics Inc stock priceInsider Buying Signals & Free Daily Market Summary and Trend Reports - earlytimes.in
Published on: 2025-10-03 06:28:34 - newser.com
Is Akebia Therapeutics Inc. stock poised for growthRate Hike & Weekly High Conviction Ideas - newser.com
Akebia Therapeutics Inc (AKBA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):